The effectiveness of breast cancer detection via mammogram has steadily improved over the last two decades. Mammography of the eigthies were grainy, high dose, x-rays, filmed at a relatively low resolution. As the technology gradually evolved from high dose, low res x-ray film to high res digital images, cancer detection rates improved from the low 70% range in 1990 to 85% detection sensitivity today. The combination of improving technology and the growing awareness of the need for breast cancer screening has increased the 5 year survival rate to now over 90% with early detection.
In the past a breast ultrasound procedure was commonly used to a obtain a clearer image of an abnormality detected by mammography or a palpable lump. Ultrasound is especially effective in determining whether a lump is a benign fluid-filled cyst or a malignant tumor. Now there is a new, advanced type of ultrasound that dramatically changes the way we can screen for breast cancer.
3-D Ultrasound technology has become a "game changer" in breast cancer screening. It's superior accuracy, ability to do an automated full breast scan in less than 2 minutes, without radiation, is a huge advantage for the detection of cancer in its earliest stage. Add to those advantages... a pain free, no compression, no pinching, diagnostic scan and you can understand the dramatic change now occurring. Next Gen's Automated 3-D allows you lay comfortably on a soft exam table, resting your breast on a radial ultrasound receiver.
The advanced level of imaging provided by this new 3-D technology provides extremely clear images of abnormal breast tissues. 3D Ultrasound is very successful at differentiating between benign and cancerous cysts. The advantage this new technology is that it is expected to reduce the number of invasive biopsy's as well as providing for a more complete diagnosis. NexGen's 3-D ultrasound (sonography) is quickly becoming a better second level diagnostic option in the place of an MRI or other more dangerous, time consuming, invasive and expensive testing options.